Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

DPhil student Neva Kandzija wins an Oxford Sparks competition to have her Placenta research transformed into a two minute animation film for free.

A huge well done to our DPhil student Neva Kandzija, who won an amazing prize from Oxford Sparks to have her Placenta research transformed into a two minute animation film called “How do unborn babies and mothers communicate via the placenta?”.

A huge well done to our DPhil student Neva Kandzija, who won an amazing prize from Oxford Sparks to have her Placenta research transformed into a two minute animation film called “How do unborn babies and mothers communicate via the placenta?”.

Click here to watch animation

Oxford Sparks are a portal for showcasing a wealth of exciting science across the University and they chose Neva as the overall winner for the Medical Sciences Division. As well as producing the animation for free, Neva’s prize included a teaching resources pack designed for secondary science teachers related to the film.

The panel included Prof David Pyle (academic lead for Oxford Sparks and MPLS academic champion for Public Engagement with Research), Kirsty Heber-Smith (Oxford Sparks website and digital media officer), Karen Sonego (producer at animators, Scriberia), Tom Fuller (video Producer in PAD), Brian Mackenwells (Public Engagement Coordinator, MSD) and one of last year’s winners, Dr Hazel Hall Roberts (Post-doctoral researcher, Pathology). 

Neva Kandzija

Commenting on her win, Neva said: “One of the most rewarding aspects of my work has been getting the word out to the general public about this disease, and letting them know what we are doing to combat it”. 

Neva’s research looks at the role of ‘small bubbles of cargo’, called extra-cellular vesicles, in the bloodstream during pregnancy, how they interact with the placenta, and how they might affect pregnancy. 

Similar stories

Dawes-Redman Education awarded funds from Huntleigh Healthcare

The Dawes-Redman Education programme which offers virtual CTG Analysis training sessions to Obstetric consultants, antenatal and student midwifes has received generous funds from Huntleigh Healthcare for the next 3 years.

First UK pilot study of newborn screening for spinal muscular atrophy (SMA) launched in Oxford

Spinal muscular atrophy (SMA) is a rare, but treatable, genetic disease affecting approximately 1 in 10,000 births, and it typically presents in infancy and early childhood.

Professor Collins awarded Sir Jules Thorn Translational Biomedical Research Award 2021

Professor Sally Collins has been awarded the prestigious and highly competitive Sir Jules Thorn Translational Biomedical Research Award 2021 for further translational development of the OxNNet Toolkit.

Global INTERCOVID-2022 Study launched to compare Covid-19 during pregnancy, with pregnant women without the infection.

The Oxford Maternal & Perinatal Health Institute (OMPHI) has launched the 2022 round of the global study to evaluate the effects of Covid-19 variants and vaccination in pregnancy.

Success with the Pfizer Maternal C-19 Vaccine Trial

Congratulations to Prof. Manu Vatish and the OSPREA-Gynae team on recruiting their first participant to the Pfizer maternal C-19 vaccine trial on 22nd July.

100 000 babies screened for increased type 1 diabetes risk in the INGR1D Study

Celebrating a major milestone for one of Europe’s biggest type 1 diabetes research cooperations: The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) has successfully screened 100,000 newborns across Europe (including over 7500 newborns in the Thames Valley) for an increased genetic risk of developing type 1 diabetes.